Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

231 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Vasoconstrictor effects in vivo and plasma disappearance rate of neuropeptide Y in man.
Pernow J, Lundberg JM, Kaijser L. Pernow J, et al. Life Sci. 1987 Jan 5;40(1):47-54. doi: 10.1016/0024-3205(87)90251-7. Life Sci. 1987. PMID: 3796213
Cardiovascular effects and cardiopulmonary plasma gradients following intravenous infusion of neuropeptide Y in humans: negative dromotropic effect on atrioventricular node conduction.
Ullman B, Pernow J, Lundberg JM, Aström H, Bergfeldt L. Ullman B, et al. Among authors: pernow j. Clin Sci (Lond). 2002 Dec;103(6):535-42. doi: 10.1042/cs1030535. Clin Sci (Lond). 2002. PMID: 12444905
Selective endothelin ETA and dual ET(A)/ET(B) receptor blockade improve endothelium-dependent vasodilatation in patients with type 2 diabetes and coronary artery disease.
Rafnsson A, Shemyakin A, Pernow J. Rafnsson A, et al. Among authors: pernow j. Life Sci. 2014 Nov 24;118(2):435-9. doi: 10.1016/j.lfs.2014.02.026. Epub 2014 Mar 5. Life Sci. 2014. PMID: 24607773 Clinical Trial.
Co-release of neuropeptide Y and catecholamines upon adrenal activation in the cat.
Lundberg JM, Fried G, Pernow J, Theodorsson-Norheim E. Lundberg JM, et al. Among authors: pernow j. Acta Physiol Scand. 1986 Feb;126(2):231-8. doi: 10.1111/j.1748-1716.1986.tb07810.x. Acta Physiol Scand. 1986. PMID: 3754683
Plasma neuropeptide Y-like immunoreactivity and catecholamines during various degrees of sympathetic activation in man.
Pernow J, Lundberg JM, Kaijser L, Hjemdahl P, Theodorsson-Norheim E, Martinsson A, Pernow B. Pernow J, et al. Among authors: pernow b. Clin Physiol. 1986 Dec;6(6):561-78. doi: 10.1111/j.1475-097x.1986.tb00789.x. Clin Physiol. 1986. PMID: 3466738
Actions of calcium antagonists on pre- and postjunctional effects of neuropeptide Y on human peripheral blood vessels in vitro.
Pernow J, Svenberg T, Lundberg JM. Pernow J, et al. Eur J Pharmacol. 1987 Apr 14;136(2):207-18. doi: 10.1016/0014-2999(87)90712-6. Eur J Pharmacol. 1987. PMID: 3595720
Neuropeptide Y and sympathetic vascular control in man.
Lundberg JM, Torssell L, Sollevi A, Pernow J, Theodorsson Norheim E, Anggård A, Hamberger B. Lundberg JM, et al. Among authors: pernow j. Regul Pept. 1985 Dec;13(1):41-52. doi: 10.1016/0167-0115(85)90085-0. Regul Pept. 1985. PMID: 3841402
Mechanisms underlying pre- and postjunctional effects of neuropeptide Y in sympathetic vascular control.
Pernow J, Saria A, Lundberg JM. Pernow J, et al. Acta Physiol Scand. 1986 Feb;126(2):239-49. doi: 10.1111/j.1748-1716.1986.tb07811.x. Acta Physiol Scand. 1986. PMID: 3010640
Neuropeptide Y and noradrenaline mechanisms in relation to reserpine induced impairment of sympathetic neurotransmission in the cat spleen.
Lundberg JM, Pernow J, Fried G, Anggärd A. Lundberg JM, et al. Among authors: pernow j. Acta Physiol Scand. 1987 Sep;131(1):1-10. doi: 10.1111/j.1748-1716.1987.tb08198.x. Acta Physiol Scand. 1987. PMID: 2890260
C-peptide potentiates the vasoconstrictor effect of neuropeptide Y in insulin-dependent diabetic patients.
Johansson BL, Pernow J. Johansson BL, et al. Among authors: pernow j. Acta Physiol Scand. 1999 Jan;165(1):39-44. doi: 10.1046/j.1365-201x.1999.00475.x. Acta Physiol Scand. 1999. PMID: 10072095
231 results
Jump to page
Feedback